Remedy Meds Review: Cost & Is It Legit?

Remedy Meds is run by Remedy Meds LLC, a Delaware company based at 480 Morris Ave, Summit, New Jersey. It belongs to Better Life Health, Inc., also of Summit, which also owns Prime Health and Titan. Its filing with Oregon's health authority says Better Life Health was founded in 2024, had about 23 full-time staff in July 2025, and is majority-owned by Haris Memon, whom the Better Business Bureau lists as CEO.

In September 2025, Remedy Meds announced a deal to buy Thirty Madison, the company behind Keeps, Nurx and Cove, paid in stock. Oregon's health authority approved the transaction on October 22, 2025. We found no announcement that the deal had closed by October 24, 2026.

Remedy Meds says it "does not practice medicine or pharmacy". The care comes from outside medical groups, which its terms name as OpenLoop Healthcare Partners, PC, JMP Medical, P.A. and KMG Medical Group MO, P.C. Its consent form says: "Your provider may be a nurse practitioner or physician assistant, not a physician."

Remedy sells compounded semaglutide and tirzepatide as weekly injections, and a "Microdose Plan" with "half the dose, twice a week". It also offers brand-name Ozempic and Zepbound at what it calls retail pricing, with no price on the page. Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved; the safety section explains what that means. For the drugs themselves, see our pages on compounded semaglutide and compounded tirzepatide.

Remedy Meds costs $299 every 28 days for compounded semaglutide and $399 for compounded tirzepatide, after a first 28 days at $179 or $279, on its product pages read on October 24, 2026. The product pages offer "$120 off — first month"; the home page shows no price. Its parent company gave Oregon's health authority the same range, "$299 to $399, depending on the medication prescribed."

| Plan | First 28 days | Every 28 days after | First year (13 charges) | | --- | --- | --- | --- | | Compounded semaglutide | $179 | $299 | $3,767 | | Compounded tirzepatide | $279 | $399 | $5,067 |

Prices read on Remedy's product pages on October 24, 2026; billing every 28 days per its help center.

The price is the same at every dose: "Your price never rises — even if dose does."

"Monthly" means every 28 days. "All subscriptions at Remedy Meds are automatically charged on a monthly basis (every 28 days)." That is 13 charges a year.

You can be charged without a shipment. The terms say your charges "will continue even if you do not complete the refill form and do not receive a medication shipment in a given period." A help article is titled "Why was I charged without receiving medication?"

The terms also mention 3-, 6- and 12-month bundles, billed up front for the whole term and not refundable. Remedy publishes no price for them. If you have side effects, talk to your provider.

Remedy Meds charges no separate membership fee: on October 24, 2026, its home page and help center said the price every 28 days covers the medication, clinician visits, "any necessary lab work" and shipping, with "no separate membership fees". The terms add that a clinician may ask for consults or lab tests "not included in the Program Membership". Remedy does not take insurance; it takes cards and HSA or FSA cards.

Remedy Meds compounded tirzepatide costs $399 every 28 days, after a first 28 days at $279, on its product page read on October 24, 2026. The price is the same at every dose. The first year, 13 charges, comes to $5,067. Its parent company's Oregon filing puts the top of its range at $399. Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound or Mounjaro.

Remedy Meds has an open FDA warning letter dated September 9, 2025. It is a registered telehealth company with named medical groups and a parent company that files with state regulators, but it names no pharmacy, and the Better Business Bureau rates it F.

The letter is about marketing. In August 2025 the FDA found product names on remedymeds.com that read "Same active ingredient as Ozempic and Wegovy" and "Same active ingredient as Mounjaro and Zepbound". It said these claims "imply that your products are the same as an FDA-approved product when they are not." The pages we read in October 2026 no longer show those lines, but the plan names in the site's code still carry them. The FDA has posted no response from Remedy and no close-out.

The pharmacy is not named. The product pages say the medication comes from a "Licensed 503A pharmacy" and that every batch is tested for potency, sterility, pH and endotoxins, but they name neither the pharmacy nor the lab. A 503A pharmacy prepares a drug for a named patient on a prescription and is regulated by its state board. Remedy's consent form says prescriptions are filled by its medical groups' "pharmacy partners". Without a name, no pharmacy record can be checked.

Its leadership is thin on clinical credentials. The patient manual names Mohit Joshipura as Chief Medical Officer, listed with a bachelor's degree from Texas Tech University, and gives no medical credential for him or the two other people it names. The product pages promise "licensed MD care" and a "Real MD review", while the consent form says your provider may be a nurse practitioner or physician assistant.

Its reputation splits by source. On October 24, 2026, the Better Business Bureau rated Remedy Meds LLC F with 491 complaints in three years, while Trustpilot showed a 4.5 TrustScore from about 13,900 reviews that Remedy invites customers to write. The customers section has the detail.

You answer a health questionnaire online, and a licensed clinician reviews it within 24 hours and decides whether you need a video visit first. If you are prescribed, the medication ships from a pharmacy partner. Each 28-day shipment holds four weekly doses, and you fill in a refill form in the third week to get the next one.

After that first review, refill reviews may be done in writing unless you or the clinician ask for a visit. Video visits are included, and Remedy says same-day visits are often available.

The care team is separate from the clinicians. Remedy's terms call its care team "non-clinical customer support" that cannot give medical advice. It answers by phone, text and email from 8am to 8pm Eastern, every day.

Labs are part of the program. The patient manual says lab costs "are covered for you", through Quest, LabCorp or BioReference, and that results up to 24 months old can be used.

Delivery times vary by page. The home page says medication "Ships within 48 hours", while the help center says it is "shipped directly to your house within 7 business days" and that pharmacies do not ship Friday to Sunday.

Remedy says it serves 49 states, all but Louisiana.

Remedy Meds has an open FDA warning letter, MARCS-CMS 716830, dated September 9, 2025. The FDA reviewed remedymeds.com in August 2025 and objected to two claims, "Semaglutide (Compounded) Same active ingredient as Ozempic and Wegovy" and "Tirzepatide (Compounded) Same active ingredient as Mounjaro and Zepbound", as false or misleading. The letter makes no finding about safety, sterility or quality. As of October 24, 2026, the FDA has posted no response and no close-out, and no other letter names Remedy Meds.

What changed since: the home page now says the compounded drugs are not evaluated by the FDA "for safety, quality, or efficacy", and its safety page says compounded semaglutide "is not FDA approved". The plan names in the site's code still use the wording the FDA cited. One newer line in its FAQ says your medication "is prepared by our compounding pharmacy", although its terms say the company does not practice pharmacy.

Remedy Meds is also named, though not sued, in a pending class action. Day v. OpenLoop Health Inc., filed in federal court in Delaware on November 20, 2025, accuses OpenLoop Health and the pharmacy Triad Rx of selling ineffective oral tirzepatide through many telehealth storefronts, and lists Remedy Meds among them. Remedy's terms name an OpenLoop medical group among its providers. These are allegations, not findings, and the case was undecided on October 24, 2026. On October 24, 2026, its old oral tirzepatide address redirected to the home page.

Because the letter is open, we do not recommend Remedy Meds or link to it while the letter stands.

The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12. Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility. Remedy says its pharmacy is a 503A pharmacy but does not name it, so its record can't be checked.

You cancel in the patient portal: Profile, then "Cancel Plan". Do it at least 48 hours before your renewal date, or the next 28 days are charged.

The refund rule is strict. "Once your payment has been processed, you are no longer eligible for a refund." The one exception: if a clinician finds you ineligible when you first enroll, you get your first payment back in full. Renewals can be billed up to ten days early.

The guarantee has conditions. The home page promises "Guaranteed or it's free" and a "365-Day Money-Back Guarantee". The terms call it a Weight Loss Warranty: you get back the fees of your first 12 months only if you miss the goal weight you set at sign-up after 12 months without a gap, 13 shipments and every refill form on time. It applies to new customers who used no other weight-loss drug in the year before, on standard-dose compounded drugs, not microdosing or brand-name drugs, and you must claim within 35 days of the 13th shipment with a provider's note or a scale video. The product pages add that it is "Only valid for month-to-month-plans". The final decision is "at the sole discretion of the Company". If you have side effects, talk to your provider.

Customer ratings split sharply by site. Remedy Meds has a 4.5 TrustScore on Trustpilot from about 13,900 reviews, 86% of them five stars and 6% one star. On the Better Business Bureau, Remedy Meds LLC is rated F and is not accredited, with 491 complaints in three years and 372 in the last 12 months; its 104 customer reviews there average 1.79 out of 5.

The difference is partly who is asked. Remedy invites customers to review it on Trustpilot and replies to almost every negative review. The good reviews praise fast shipping, helpful clinicians and video visits.

The complaints repeat one theme: billing. One-star Trustpilot reviews and recent BBB complaints describe charges every 28 days that continued after canceling or when no medication shipped, refunds refused, the weight-loss guarantee turned down, and refills held up at the pharmacy. The BBB gives its F for complaints the company did not answer or resolve. That matches Remedy's own terms, which keep billing when no refill ships and refund nothing once paid.

Remedy's own figures are marketing. Its home page says members "lose 45 lbs in their first 6 months" on semaglutide, based on self-reported weights, and that it has written 1,200,000+ prescriptions. Its testimonials are paid: "Members were compensated for their testimonials." This site collects no independent reviews of its own yet.

Our score combines seven checks. Each one counts for a fixed share of the total, listed below. Commission is not an input.

• Price transparency: 8.5/10 (counts for 20% of the total score). Both compounded prices and the first-month discount are on its product pages, the same at every dose, with no separate fees. The home page shows none, and the bundle and brand-name prices are not published.
• Cost and value: 2/10 (counts for 15% of the total score). We compare month-to-month prices: $299 for semaglutide ranks 15 of 17 programs that sell both compounded and brand-name drugs, against a median of $200.
• Medication and pharmacy traceability: 6.5/10 (counts for 15% of the total score). It states a 503A pharmacy but names none, so nothing can be found in the FDA's records.
• Clinical access and oversight: 7/10 (counts for 15% of the total score). Named medical groups, a stated review time, video visits and labs included, but no clinician named with a clinical credential.
• Safety and enforcement: 6.8/10 (counts for 20% of the total score). An open FDA warning letter to Remedy Meds, dated September 9, 2025, with no close-out.
• Terms, commitment and refunds: 10/10 (counts for 10% of the total score). No minimum term, cancel in the portal with no fee, and a stated refund rule.
• Availability and fulfillment: 8.7/10 (counts for 5% of the total score). 49 states, free shipping and a stated delivery time, though its pages give several.

This is the first score for Remedy Meds. Confidence is low: we have read its prices once and have not yet captured its pages over time. No check carries an editor's adjustment. The method is on our methodology page.